482 related articles for article (PubMed ID: 15303780)
41. A multi-center, open-label study to evaluate the safety and efficacy of a sequential treatment regimen of clobetasol propionate 0.05% spray followed by Calcitriol 3 mg/g ointment in the management of plaque psoriasis.
Brodell RT; Bruce S; Hudson CP; Weiss JS; Colón LE; Johnson LA; Gottschalk RW
J Drugs Dermatol; 2011 Feb; 10(2):158-64. PubMed ID: 21283920
[TBL] [Abstract][Full Text] [Related]
42. Efficacy and safety of calcipotriol plus betamethasone dipropionate scalp formulation compared with calcipotriol scalp solution in the treatment of scalp psoriasis: a randomized controlled trial.
Kragballe K; Hoffmann V; Ortonne JP; Tan J; Nordin P; Segaert S
Br J Dermatol; 2009 Jul; 161(1):159-66. PubMed ID: 19416259
[TBL] [Abstract][Full Text] [Related]
43. Treatment of nail psoriasis with 8% clobetasol nail lacquer: positive experience in 10 patients.
Sánchez Regaña M; Martín Ezquerra G; Umbert Millet P; Llambí Mateos F
J Eur Acad Dermatol Venereol; 2005 Sep; 19(5):573-7. PubMed ID: 16164711
[TBL] [Abstract][Full Text] [Related]
44. Comparison of clobetasol propionate cream plus coal tar vs. topical psoralen and solar ultraviolet A therapy in palmoplantar psoriasis.
Khandpur S; Sharma VK
Clin Exp Dermatol; 2011 Aug; 36(6):613-6. PubMed ID: 21507036
[TBL] [Abstract][Full Text] [Related]
45. Remission and relapse of chronic plaque psoriasis treated once a week with clobetasol propionate occluded with a hydrocolloid dressing versus twice daily treatment with clobetasol propionate alone.
Volden G; Kragballe K; Van De Kerkhof PC; Aberg K; White RJ
J Dermatolog Treat; 2001 Sep; 12(3):141-4. PubMed ID: 12243704
[TBL] [Abstract][Full Text] [Related]
46. Gene expression profiling in psoriatic scalp hair follicles: clobetasol propionate shampoo 0.05% normalizes psoriasis disease markers.
Aubert J; Reiniche P; Fogel P; Poulin Y; Lui H; Lynde C; Shapiro J; Villemagne H; Soto P; Voegel JJ
J Eur Acad Dermatol Venereol; 2010 Nov; 24(11):1304-11. PubMed ID: 20337827
[TBL] [Abstract][Full Text] [Related]
47. A double-blind randomized trial of 0.1% tacrolimus vs 0.05% clobetasol for the treatment of childhood vitiligo.
Lepe V; Moncada B; Castanedo-Cazares JP; Torres-Alvarez MB; Ortiz CA; Torres-Rubalcava AB
Arch Dermatol; 2003 May; 139(5):581-5. PubMed ID: 12756094
[TBL] [Abstract][Full Text] [Related]
48. Improvement in signs and symptoms of plaque psoriasis after 1 week of treatment with clobetasol propionate 0.05% spray.
Brodell R; Preston N
J Drugs Dermatol; 2012 Dec; 11(12):1455-9. PubMed ID: 23377516
[TBL] [Abstract][Full Text] [Related]
49. Quality of life in patients with scalp psoriasis treated with calcipotriol/betamethasone dipropionate scalp formulation: a randomized controlled trial.
Ortonne JP; Ganslandt C; Tan J; Nordin P; Kragballe K; Segaert S
J Eur Acad Dermatol Venereol; 2009 Aug; 23(8):919-26. PubMed ID: 19453810
[TBL] [Abstract][Full Text] [Related]
50. Clobetasol propionate 0.05% under occlusion in the treatment of alopecia totalis/universalis.
Tosti A; Piraccini BM; Pazzaglia M; Vincenzi C
J Am Acad Dermatol; 2003 Jul; 49(1):96-8. PubMed ID: 12833016
[TBL] [Abstract][Full Text] [Related]
51. Calcitriol 3 microg/g ointment in the management of mild to moderate plaque type psoriasis: results from 2 placebo-controlled, multicenter, randomized double-blind, clinical studies.
Lebwohl M; Menter A; Weiss J; Clark SD; Flores J; Powers J; Balin AK; Kempers S; Glinert RJ; Fleming T; Liu Y; Graeber M; Pariser DM
J Drugs Dermatol; 2007 Apr; 6(4):428-35. PubMed ID: 17668541
[TBL] [Abstract][Full Text] [Related]
52. The efficacy and tolerability of clobetasol propionate foam 0.05% in the treatment of mild to moderate plaque-type psoriasis of nonscalp regions.
Gottlieb AB; Ford RO; Spellman MC
J Cutan Med Surg; 2003; 7(3):185-92. PubMed ID: 12704534
[TBL] [Abstract][Full Text] [Related]
53. Vitamin D and scalp psoriasis.
Koo J
Cutis; 2002 Nov; 70(5 Suppl):21-4. PubMed ID: 12467336
[TBL] [Abstract][Full Text] [Related]
54. A new delivery system of clobetasol-17-propionate (lipid-loaded microspheres 0.025%) compared with a conventional formulation (lipophilic ointment in a hydrophilic phase 0.025%) in topical treatment of atrophic/erosive oral lichen planus. A Phase IV, randomized, observer-blinded, parallel group clinical trial.
Campisi G; Giandalia G; De Caro V; Di Liberto C; Aricò P; Giannola LI
Br J Dermatol; 2004 May; 150(5):984-90. PubMed ID: 15149513
[TBL] [Abstract][Full Text] [Related]
55. Efficacy of Iralfaris shampoo in the treatment of scalp psoriasis: a videodermoscopy evaluation prospective study in 70 patients.
Rossi A; Pranteda G; Iorio A; Mari E; Milani M
G Ital Dermatol Venereol; 2012 Dec; 147(6):625-30. PubMed ID: 23149708
[TBL] [Abstract][Full Text] [Related]
56. The efficacy of '0.05% Clobetasol + 2.5% zinc sulphate' cream vs. '0.05% Clobetasol alone' cream in the treatment of the chronic hand eczema: a double-blind study.
Faghihi G; Iraji F; Shahingohar A; Saidat A
J Eur Acad Dermatol Venereol; 2008 May; 22(5):531-6. PubMed ID: 18284511
[TBL] [Abstract][Full Text] [Related]
57. Topical monotherapy with clobetasol propionate spray 0.05% in the COBRA trial.
Menter A
Cutis; 2007 Nov; 80(5 Suppl):12-9. PubMed ID: 18154219
[TBL] [Abstract][Full Text] [Related]
58. Treatment and prophylaxis of seborrheic dermatitis of the scalp with antipityrosporal 1% ciclopirox shampoo.
Shuster S; Meynadier J; Kerl H; Nolting S
Arch Dermatol; 2005 Jan; 141(1):47-52. PubMed ID: 15655141
[TBL] [Abstract][Full Text] [Related]
59. Scalp psoriasis: topical calcipotriol 50 micrograms/g/ml solution vs. betamethasone valerate 1% lotion.
Duweb GA; Abuzariba O; Rahim M; al-Taweel M; Abdulla SA
Int J Clin Pharmacol Res; 2000; 20(3-4):65-8. PubMed ID: 11314240
[TBL] [Abstract][Full Text] [Related]
60. The two-compound formulation of calcipotriol and betamethasone dipropionate for treatment of moderately severe body and scalp psoriasis - an introduction.
Freeman K
Curr Med Res Opin; 2011 Jan; 27(1):197-203. PubMed ID: 21142834
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
